688331 榮昌生物
按盤價 
123.900 -6.100 (-4.692%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.704 | 25.367 | -54.148 | -35.907 | -23.706 |
| 總資產報酬率 ROA (%) | 4.489 | 11.135 | -26.633 | -26.170 | -19.623 |
| 投入資產回報率 ROIC (%) | 5.261 | 13.140 | -31.295 | -30.278 | -22.301 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.177 | 87.280 | 80.362 | 77.432 | 64.766 |
| 營業利潤率 (%) | 50.314 | 22.227 | -84.786 | -138.651 | -128.900 |
| 息稅前利潤/營業總收入 (%) | 51.463 | 23.845 | -81.479 | -140.043 | -138.154 |
| 淨利潤/營業總收入 (%) | 49.985 | 21.828 | -85.526 | -139.547 | -129.364 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -12.379 | 8.708 | 102.862 | 102.567 | 112.858 |
| 價值變動淨收益/利潤總額(%) | 109.844 | 89.566 | 0.188 | -0.462 | -1.212 |
| 營業外收支淨額/利潤總額(%) | -0.510 | -1.718 | 0.865 | 0.642 | 0.359 | 償債能力分析 |
| 流動比率 (X) | 1.581 | 1.429 | 1.051 | 1.976 | 3.663 |
| 速動比率 (X) | 1.311 | 1.191 | 0.748 | 1.318 | 3.067 |
| 資產負債率 (%) | 46.662 | 50.210 | 63.878 | 37.823 | 17.287 |
| 帶息債務/全部投入資本 (%) | 35.015 | 39.288 | 54.412 | 24.653 | 2.168 |
| 股東權益/帶息債務 (%) | 177.298 | 149.570 | 78.335 | 295.139 | 4,368.385 |
| 股東權益/負債合計 (%) | 114.308 | 99.164 | 56.550 | 164.386 | 478.465 |
| 利息保障倍數 (X) | 36.655 | 11.958 | -20.133 | 282.448 | 15.718 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.175 | 44.635 | 71.405 | 83.057 | 47.638 |
| 存貨周轉天數 (天) | 524.865 | 574.923 | 747.907 | 931.109 | 531.299 |
| 備註： | 即時報價更新時間為 08/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
